Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis
Voriconazole is one of the most used antifungal azoles against pulmonary aspergillosis. Therapeutic drug monitoring (TDM) of the voriconazole concentration in plasma is recommended in clinical practice guidelines to prevent treatment failure and toxicity. The aim of this study was to evaluate the fe...
Saved in:
Main Authors: | Sacha Sarfati (Author), Julien Wils (Author), Timothée Lambert (Author), Céline Mory (Author), Laurent Imbert (Author), Gilles Gargala (Author), Hélène Morisse-Pradier (Author), Fabien Lamoureux (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies
by: Kem P Krueger, et al.
Published: (2009) -
Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
by: Grau S, et al.
Published: (2016) -
A Novel Inhalable Dry Powder to Trigger Delivery of Voriconazole for Effective Management of Pulmonary Aspergillosis
by: Alanood S. Almurshedi, et al.
Published: (2024) -
Successful treatment of multiple intracerebral aspergillosis with voriconazole alone in an Egyptian diabetic patient with autoimmune hemolytic anemia
by: Hamdy Ibrahim, et al.
Published: (2023) -
Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis
by: Milo Gatti, et al.
Published: (2023)